Literature DB >> 18980945

Emerging role of Toll-like receptors in atherosclerosis.

Linda K Curtiss1, Peter S Tobias.   

Abstract

Atherosclerosis is inflammation of the vessel wall of the arterial tree. This inflammation arises at specific areas that experience disturbed blood flow such as bifurcations and the lesser curvature of the aortic arch. Although all endothelial cells are exposed to comparable levels of circulating plasma cholesterol, only endothelial cells overlaying lesions display an inflamed phenotype. This occurs even in the absence of any additional exacerbating disease factors because blood flow controls the expression of Toll-like receptors (TLR), which are initiators of cellular activation and inflammation. TLR2- and 4-expression exert an overall proatherogenic effect in hyperlipidemic mice. TLR activation of the endothelium promotes lipid accumulation and leukocyte accumulation within lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18980945      PMCID: PMC2674724          DOI: 10.1194/jlr.R800056-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  71 in total

Review 1.  TLR signaling: an emerging bridge from innate immunity to atherogenesis.

Authors:  Kathrin S Michelsen; Terence M Doherty; Prediman K Shah; Moshe Arditi
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

2.  Phosphocholine as a pattern recognition ligand for CD36.

Authors:  Agnès Boullier; Peter Friedman; Richard Harkewicz; Karsten Hartvigsen; Simone R Green; Felicidad Almazan; Edward A Dennis; Daniel Steinberg; Joseph L Witztum; Oswald Quehenberger
Journal:  J Lipid Res       Date:  2005-02-01       Impact factor: 5.922

3.  Differential induction of apoptosis by LPS and taxol in monocytic cells.

Authors:  Tao Li; Jean Hu; James A Thomas; Liwu Li
Journal:  Mol Immunol       Date:  2004-12-07       Impact factor: 4.407

4.  A mechanosensory complex that mediates the endothelial cell response to fluid shear stress.

Authors:  Eleni Tzima; Mohamed Irani-Tehrani; William B Kiosses; Elizabetta Dejana; David A Schultz; Britta Engelhardt; Gaoyuan Cao; Horace DeLisser; Martin Alexander Schwartz
Journal:  Nature       Date:  2005-09-15       Impact factor: 49.962

5.  The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?

Authors:  Stefan Blankenberg; Salim Yusuf
Journal:  Circulation       Date:  2006-10-10       Impact factor: 29.690

Review 6.  Mechanisms of disease: atherosclerosis in autoimmune diseases.

Authors:  Yaniv Sherer; Yehuda Shoenfeld
Journal:  Nat Clin Pract Rheumatol       Date:  2006-02

Review 7.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal.

Authors:  Michael T Lotze; Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2005-04       Impact factor: 53.106

Review 8.  Multiple roles of Toll-like receptor signaling in atherosclerosis.

Authors:  Harry Björkbacka
Journal:  Curr Opin Lipidol       Date:  2006-10       Impact factor: 4.776

9.  Conditional signaling by Toll-like receptor 4.

Authors:  Gregory J Brunn; Marlo K Bungum; Geoffrey B Johnson; Jeffrey L Platt
Journal:  FASEB J       Date:  2005-02-28       Impact factor: 5.191

10.  Cellular physiology of cholesterol efflux in vascular endothelial cells.

Authors:  Brian J O'Connell; Maxime Denis; Jacques Genest
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

View more
  85 in total

1.  TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia.

Authors:  Sudipta Biswas; Alejandro Zimman; Detao Gao; Tatiana V Byzova; Eugene A Podrez
Journal:  Circ Res       Date:  2017-08-03       Impact factor: 17.367

2.  Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice.

Authors:  Ru Liu-Bryan; Robert Terkeltaub
Journal:  Arthritis Rheum       Date:  2010-07

Review 3.  The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis.

Authors:  Edward Thorp; Manikandan Subramanian; Ira Tabas
Journal:  Eur J Immunol       Date:  2011-09       Impact factor: 5.532

Review 4.  microRNAs in the regulation of dendritic cell functions in inflammation and atherosclerosis.

Authors:  Martin Busch; Alma Zernecke
Journal:  J Mol Med (Berl)       Date:  2012-02-04       Impact factor: 4.599

5.  Regulatory T cells and Atherosclerosis.

Authors:  Jahaira Lopez Pastrana; Xiaojin Sha; Anthony Virtue; Jietang Mai; Ramon Cueto; In Ae Lee; Hong Wang; Xiao-Feng Yang
Journal:  J Clin Exp Cardiolog       Date:  2012-10-08

Review 6.  Atherosclerosis: current pathogenesis and therapeutic options.

Authors:  Christian Weber; Heidi Noels
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

7.  Obesity and the gut microbiome: Striving for causality.

Authors:  Isaac T W Harley; Christopher L Karp
Journal:  Mol Metab       Date:  2012-08-03       Impact factor: 7.422

Review 8.  Mechanisms that regulate macrophage burden in atherosclerosis.

Authors:  Gwendalyn J Randolph
Journal:  Circ Res       Date:  2014-05-23       Impact factor: 17.367

Review 9.  Matricryptic sites control tissue injury responses in the cardiovascular system: relationships to pattern recognition receptor regulated events.

Authors:  George E Davis
Journal:  J Mol Cell Cardiol       Date:  2009-09-12       Impact factor: 5.000

Review 10.  Macrophage death and defective inflammation resolution in atherosclerosis.

Authors:  Ira Tabas
Journal:  Nat Rev Immunol       Date:  2009-12-04       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.